ES2048417T3 - Medios de contraste en particulas. - Google Patents

Medios de contraste en particulas.

Info

Publication number
ES2048417T3
ES2048417T3 ES90201963T ES90201963T ES2048417T3 ES 2048417 T3 ES2048417 T3 ES 2048417T3 ES 90201963 T ES90201963 T ES 90201963T ES 90201963 T ES90201963 T ES 90201963T ES 2048417 T3 ES2048417 T3 ES 2048417T3
Authority
ES
Spain
Prior art keywords
particles
contrast means
magnetic resonance
contrast medium
physiologically tolerable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90201963T
Other languages
English (en)
Spanish (es)
Inventor
Gundersen
Klaveness
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed Imaging AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging AS filed Critical Nycomed Imaging AS
Application granted granted Critical
Publication of ES2048417T3 publication Critical patent/ES2048417T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806Suspensions, emulsions, colloids, dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/24Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Glass Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Optical Modulation, Optical Deflection, Nonlinear Optics, Optical Demodulation, Optical Logic Elements (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
ES90201963T 1989-07-21 1990-07-19 Medios de contraste en particulas. Expired - Lifetime ES2048417T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898916782A GB8916782D0 (en) 1989-07-21 1989-07-21 Compositions

Publications (1)

Publication Number Publication Date
ES2048417T3 true ES2048417T3 (es) 1994-03-16

Family

ID=10660461

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90201963T Expired - Lifetime ES2048417T3 (es) 1989-07-21 1990-07-19 Medios de contraste en particulas.

Country Status (13)

Country Link
US (1) US5346690A (da)
EP (2) EP0483278A1 (da)
JP (1) JPH04506970A (da)
AT (1) ATE100333T1 (da)
AU (1) AU641677B2 (da)
CA (1) CA2062949A1 (da)
DE (1) DE69006136T2 (da)
DK (1) DK0414287T3 (da)
ES (1) ES2048417T3 (da)
FI (1) FI98986C (da)
GB (1) GB8916782D0 (da)
NO (1) NO302685B1 (da)
WO (1) WO1991001147A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102652A (en) * 1986-07-03 1992-04-07 Advanced Magnetics Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
US5370901A (en) * 1991-02-15 1994-12-06 Bracco International B.V. Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
US5179955A (en) * 1991-02-22 1993-01-19 Molecular Biosystems, Inc. Method of abdominal ultrasound imaging
EP0593627A1 (en) * 1991-07-05 1994-04-27 The University Of Rochester Ultrasmall non-aggregated porous particles entrapping gas-bubbles
WO1995020405A1 (en) * 1994-01-28 1995-08-03 Nycomed Imaging As Oral magnetic particle formulation
FR2736051B3 (fr) * 1995-06-29 1997-09-26 Guerbet Sa Complexes metalliques de polyaminoacides, leur procede de preparation et leur utilisation en imagerie diagnostique
GB9603547D0 (en) * 1996-02-20 1996-04-17 Nycomed Imaging As Contrast media
EP1031354A3 (en) 1999-01-19 2003-02-05 Rohm And Haas Company Polymeric MRI Contrast agents
KR20040071143A (ko) * 2001-11-21 2004-08-11 이-지-이엠, 인코포레이티드 의료 또는 진단 절차에 사용하기 위한 조성물
WO2006069677A2 (en) * 2004-12-30 2006-07-06 Cinvention Ag Combination comprising an agent providing a signal, an implant material and a drug
ATE412691T1 (de) * 2005-01-13 2008-11-15 Cinv Ag Kohlenstoffnanopartikel enthaltende verbundwerkstoffe
MX2007011388A (es) * 2005-03-18 2007-11-13 Cinv Ag Proceso para la preparacion de materiales metalicos sinterizados porosos.
KR100695744B1 (ko) * 2005-05-03 2007-03-19 한국원자력연구소 디티피에이(dtpa) 유도체 및 이들을 이용한 금속 착화물, 이들을 포함하는 방사선원 및 조영제
AU2006265196A1 (en) * 2005-07-01 2007-01-11 Cinvention Ag Medical devices comprising a reticulated composite material
US20100259259A1 (en) * 2005-09-21 2010-10-14 Markus Zahn Systems and methods for tuning properties of nanoparticles
AU2006303324A1 (en) * 2005-10-18 2007-04-26 Cinvention Ag Thermoset particles and methods for production thereof
US9585973B1 (en) 2008-06-05 2017-03-07 Peter Quagliano Palatable liquid dilution vehicles for oral contrast agents
DE102009054956A1 (de) * 2009-12-18 2011-06-22 Siemens Aktiengesellschaft, 80333 Magnetresonanztomographie-Bildgebung
JPWO2021172030A1 (da) * 2020-02-28 2021-09-02

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3316703A1 (de) * 1983-05-04 1984-11-08 Schering AG, 1000 Berlin und 4709 Bergkamen Orales kontrastmittel fuer die kernspintomographie und dessen herstellung
US4698302A (en) * 1983-05-12 1987-10-06 Advanced Magnetics, Inc. Enzymatic reactions using magnetic particles
CA1211147A (en) * 1984-03-27 1986-09-09 Prahlada R. Batni (Deceased) Tandem commutatorless dc machine
GB8408127D0 (en) * 1984-03-29 1984-05-10 Nyegaard & Co As Contrast agents
EP0184899B1 (en) * 1984-11-01 1990-04-18 Nycomed As Paramagnetic contrast agents for use in "in vivo" diagnostic methods using nmr, and their preparation
SE465907B (sv) * 1984-11-01 1991-11-18 Nyegaard & Co As Diagnosticeringsmedel innehaallande en paramagnetisk metall
US5141739A (en) * 1986-07-03 1992-08-25 Advanced Magnetics, Inc. Delivery of x-ray contrast agents using receptor mediated endocytosis
DE3709851A1 (de) * 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te Nmr-diagnostische fluessigkeitszusammensetzungen
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
GB8916781D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions

Also Published As

Publication number Publication date
EP0414287A1 (en) 1991-02-27
WO1991001147A1 (en) 1991-02-07
DK0414287T3 (da) 1994-02-28
DE69006136T2 (de) 1994-05-05
NO302685B1 (no) 1998-04-14
NO920264L (no) 1992-01-20
US5346690A (en) 1994-09-13
CA2062949A1 (en) 1991-01-22
GB8916782D0 (en) 1989-09-06
EP0414287B1 (en) 1994-01-19
AU6163390A (en) 1991-02-22
DE69006136D1 (de) 1994-03-03
FI920236A0 (fi) 1992-01-20
NO920264D0 (no) 1992-01-20
JPH04506970A (ja) 1992-12-03
FI98986C (fi) 1997-09-25
EP0483278A1 (en) 1992-05-06
ATE100333T1 (de) 1994-02-15
FI98986B (fi) 1997-06-13
AU641677B2 (en) 1993-09-30

Similar Documents

Publication Publication Date Title
ES2048417T3 (es) Medios de contraste en particulas.
DE69029667D1 (de) Magnetisches Aufzeichnungs- und Wiedergabegerät
NO975772D0 (no) Ferromagnetisk partikkel med glassoverflate
DE69122326D1 (de) Magnetisches Speichersystem und Betriebsweise
GB8819778D0 (en) Magnetic resonance methods & apparatus
AU3739489A (en) Magnetically enhanced rie process and apparatus
DE69029709D1 (de) Magnetooptischer Aufzeichnungsträger und Vorrichtung
NZ234574A (en) A contrast medium containing magnetically responsive particles and viscosity enhancing agent; use in magnetic resonance imaging
EP0409421A3 (en) Magnetic resonance imaging methods and apparatus
DE69027182D1 (de) Magnetooptischer Aufzeichnungsträger und -gerät
DE69032436D1 (de) Vorrichtung mit magnetischer Resonanz mit einstellbarer Ausbeute eines Signalverstärkers
GB2226789B (en) Method for forming doughnut-shaped permanent magnet and forming mold therefor
GB2251491B (en) Nuclear magnetic resonance methods and apparatus
GB2220495B (en) Magnetic resonance methods and apparatus
DE68927602D1 (de) Magnetresonanz-Gerät
GB9020057D0 (en) Magnetic recording and/or reproducing apparatus
DE69413101D1 (de) "Magnetaufzeichnungs- und -wiedergabegerät"
GB8902198D0 (en) Magnetic resonance methods and apparatus
ITMI940847A0 (it) Procedimento e dispositivo per la incrinoscopia magnetica con magnetizzazione senza contatto
KR920006009U (ko) 자력을 이용한 완구의 동작장치
DE3762175D1 (de) Homogenitaetskorrektureinheit eines magnetfeldes und mit solchen einheiten ausgeruesteter magnet.
SE8903615D0 (sv) Taetning med fiberplack och magnetisk vaetska
KR940003554B1 (en) Magnetic head and disk device
DE69019469D1 (de) Magnetisches Bildaufzeichnungs- und Wiedergabegerät.
SE8803316D0 (sv) Foerfarande och anordning foer magnetseparation

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 414287

Country of ref document: ES